Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Cost of Goods Sold (Deprecated 2018-01-31)

2.5 / 5 stars · 44/89 Roast Me

NIAGEN BIOSCIENCE, INC. Cost of Goods Sold (Deprecated 2018-01-31)

NIAGEN BIOSCIENCE, INC. (NAGE) reported Cost of Goods Sold (Deprecated 2018-01-31) of $3.70 million for the 3-month period ending 2017-12-30, per its 10-K filed 2018-03-15.

Discontinued › Expense Statement

us-gaap:CostOfGoodsSold · last filed 2018-03-15

  • NIAGEN BIOSCIENCE, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-30 was $3.70M, a 51.30% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $3.17M, a 52.79% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-07-01 was $2.11M, a 43.74% decline year-over-year.
  • NIAGEN BIOSCIENCE, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-04-01 was $1.75M, a 41.83% decline year-over-year.
Period endCost of Goods Sold (Deprecated 2018-01-31) 3 monthCost of Goods Sold (Deprecated 2018-01-31) 3 month as first filedCost of Goods Sold (Deprecated 2018-01-31) 6 monthCost of Goods Sold (Deprecated 2018-01-31) 9 monthCost of Goods Sold (Deprecated 2018-01-31) 12 month
2017-12-30$3.70M
10-K · filed 2018-03-15
$6.87M
derived: sum of 2 quarters · filed 2018-03-15
$8.97M
derived: sum of 3 quarters · filed 2018-03-15
$10.72M
derived: sum of 4 quarters · filed 2018-03-15
2017-09-30$3.17M
10-K · filed 2018-03-15
$5.28M
derived: sum of 2 quarters · filed 2018-03-15
$7.03M
derived: sum of 3 quarters · filed 2018-03-15
$9.47M
derived: sum of 4 quarters · filed 2018-03-15
2017-07-01$2.11M
10-K · filed 2018-03-15
$3.86M
derived: sum of 2 quarters · filed 2018-03-15
$6.30M
derived: sum of 3 quarters · filed 2018-03-15
$8.38M
derived: sum of 4 quarters · filed 2018-03-15
2017-04-01$1.75M
10-K · filed 2018-03-15
$4.19M
derived: sum of 2 quarters · filed 2018-03-15
$6.27M
derived: sum of 3 quarters · filed 2018-03-15
$10.02M
derived: sum of 4 quarters · filed 2018-03-15
2016-12-31$2.44M
10-K · filed 2018-03-15
$3.34M
10-K · filed 2017-03-16
$4.52M
derived: sum of 2 quarters · filed 2018-03-15
$8.27M
derived: sum of 3 quarters · filed 2018-03-15
$11.27M
derived: sum of 4 quarters · filed 2018-03-15
2016-10-01$2.07M
10-K · filed 2018-03-15
$2.96M
10-K · filed 2017-03-16
$5.82M
derived: sum of 2 quarters · filed 2018-03-15
$8.83M
derived: sum of 3 quarters · filed 2018-03-15
$11.59M
derived: sum of 4 quarters · filed 2018-03-15
2016-07-02$3.75M
10-K · filed 2018-03-15
$4.70M
10-K · filed 2017-03-16
$6.76M
derived: sum of 2 quarters · filed 2018-03-15
$9.52M
derived: sum of 3 quarters · filed 2018-03-15
$13.33M
derived: sum of 4 quarters · filed 2018-03-15
2016-04-02$3.01M
10-K · filed 2018-03-15
$3.88M
10-K · filed 2017-03-16
$5.77M
derived: sum of 2 quarters · filed 2018-03-15
$9.58M
derived: sum of 3 quarters · filed 2018-03-15
$13.21M
derived: sum of 4 quarters · filed 2018-03-15
2016-01-02$2.76M
10-K · filed 2017-03-16
$6.57M
derived: sum of 2 quarters · filed 2017-03-16
$10.20M
derived: sum of 3 quarters · filed 2017-03-16
$13.53M
derived: sum of 4 quarters · filed 2017-03-16
2015-10-03$3.81M
10-K · filed 2017-03-16
$7.44M
derived: sum of 2 quarters · filed 2017-03-16
$10.77M
derived: sum of 3 quarters · filed 2017-03-16
$13.59M
derived: sum of 4 quarters · filed 2017-03-16
2015-07-04$3.63M
10-K · filed 2017-03-16
$6.96M
derived: sum of 2 quarters · filed 2017-03-16
$9.79M
derived: sum of 3 quarters · filed 2017-03-16
$12.41M
derived: sum of 4 quarters · filed 2017-03-16
2015-04-04$3.33M
10-K · filed 2017-03-16
$6.16M
derived: sum of 2 quarters · filed 2017-03-16
$8.77M
derived: sum of 3 quarters · filed 2017-03-16
$11.23M
derived: sum of 4 quarters · filed 2017-03-16
2015-01-03$2.82M
10-K · filed 2017-03-16
$5.44M
derived: sum of 2 quarters · filed 2017-03-16
$7.90M
derived: sum of 3 quarters · filed 2017-03-16
$9.99M
derived: sum of 4 quarters · filed 2017-03-16
2014-09-27$2.62M
10-K · filed 2017-03-16
$5.07M
derived: sum of 2 quarters · filed 2017-03-16
$7.16M
derived: sum of 3 quarters · filed 2017-03-16
$8.82M
derived: sum of 4 quarters · filed 2017-03-16
2014-06-28$2.46M
10-K · filed 2017-03-16
$4.55M
derived: sum of 2 quarters · filed 2017-03-16
$6.20M
derived: sum of 3 quarters · filed 2017-03-16
$8.17M
derived: sum of 4 quarters · filed 2017-03-16
2014-03-29$2.09M
10-K · filed 2017-03-16
$3.74M
derived: sum of 2 quarters · filed 2017-03-16
$5.71M
derived: sum of 3 quarters · filed 2017-03-16
$7.46M
derived: sum of 4 quarters · filed 2017-03-16
2013-12-28$1.65M
10-K · filed 2016-03-17
$3.62M
derived: sum of 2 quarters · filed 2016-03-17
$5.37M
derived: sum of 3 quarters · filed 2016-03-17
$7.03M
derived: sum of 4 quarters · filed 2016-03-17
2013-09-28$1.97M
10-K · filed 2016-03-17
$3.71M
derived: sum of 2 quarters · filed 2016-03-17
$5.38M
derived: sum of 3 quarters · filed 2016-03-17
2013-06-29$1.75M
10-K · filed 2016-03-17
$3.41M
derived: sum of 2 quarters · filed 2016-03-17
2013-03-30$1.66M
10-K · filed 2016-03-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87